相似文献
1
Nebulised salbutamol and angina.
Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):796-7. doi: 10.1136/bmj.285.6344.796.
2
[Side-effects of beta-adrenergic drugs].
Minerva Med. 1976 Mar 13;67(15):974-7.
3
Acute carbon dioxide narcosis during inhalational therapy with oxygen powered nebulizers in patients with chronic airflow limitation.
Ann Acad Med Singap. 1985 Jul;14(3):439-41.
4
Potential hazard of nebulised salbutamol in patients with haemoptysis.
Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):844-5. doi: 10.1136/bmj.286.6368.844-a.
5
Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
Br Heart J. 1994 Aug;72(2):181. doi: 10.1136/hrt.72.2.181.
6
Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.
BMJ. 1992 Feb 1;304(6822):320. doi: 10.1136/bmj.304.6822.320-a.
7
Experiences with large doses of beta 2-agonists inhaled from nebulizers.
Postgrad Med J. 1983;59 Suppl 3:71-2.
8
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
N Z Med J. 1987 May 27;100(824):309-11.
9
Use of Haleraid in rheumatoid arthritis with obstructive lung disease.
Br J Rheumatol. 1986 Aug;25(3):318. doi: 10.1093/rheumatology/25.3.318.
10
Salbutamol and cardiac arrhythmias.
Curr Med Res Opin. 1981;7(6):410-5.
引用本文的文献
1
The Acute Effects of the Use of Salbutamol and Ipratropium on the Heart Rates of Patients With Obstructive Airway Disease.
Cureus. 2023 Oct 3;15(10):e46409. doi: 10.7759/cureus.46409. eCollection 2023 Oct.
2
Salbutamol in the Management of Asthma: A Review.
Int J Mol Sci. 2022 Nov 17;23(22):14207. doi: 10.3390/ijms232214207.
3
Safety of bronchodilator reversibility test in elderly subjects: a prospective study.
Postepy Dermatol Alergol. 2021 Apr;38(2):256-261. doi: 10.5114/ada.2020.92515. Epub 2020 Feb 19.
4
Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.
Br J Clin Pharmacol. 2009 Apr;67(4):394-402. doi: 10.1111/j.1365-2125.2009.03377.x.
5
Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.
Drugs Aging. 2008;25(5):415-43. doi: 10.2165/00002512-200825050-00005.
6
Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.
Drugs Aging. 2004;21(6):405-14. doi: 10.2165/00002512-200421060-00005.
7
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.
Thorax. 1998 Jul;53(7):558-62. doi: 10.1136/thx.53.7.558.
8
Nebulisers for asthma.
Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S45-8. doi: 10.1136/thx.52.2008.s45.
9
Drug treatment of asthma in the elderly.
Drugs. 1996 Mar;51(3):415-23. doi: 10.2165/00003495-199651030-00006.
10
Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
Br Heart J. 1994 Aug;72(2):181. doi: 10.1136/hrt.72.2.181.
本文引用的文献
1
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.
Thorax. 1981 Aug;36(8):625-8. doi: 10.1136/thx.36.8.625.
2
Domiciliary nebulised salbutamol solution in severe chronic airway obstruction.
Thorax. 1980 Nov;35(11):873-6. doi: 10.1136/thx.35.11.873.
3
Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation.
Br Med J. 1970 Nov 21;4(5733):465-8. doi: 10.1136/bmj.4.5733.465.
4
Aerosol salbutamol administration by IPPB: lowest effective dose.
Thorax. 1978 Dec;33(6):689-93. doi: 10.1136/thx.33.6.689.
Zotero 插件